 CONSHOHOCKEN, Pa., March 09, 2022 GLOBE NEWSWIRE -- Madrigal Pharmaceuticals, Inc. NASDAQ: MDGL, a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis NASH, announced today its management team will participate in the 32nd Annual Oppenheimer Healthcare Conference on Tuesday, March 15, 2022 at 8:00 AM ET. 